Global Precision Medicine Market 2020, Industry Expansion Strategies and Review Forecast 2025

 KD Market Insights (KDMI) recently published market research report on the Global Precision Medicine market, this market research report provides detailed analysis of market drivers, challenges, opportunity analysis, and trends, along with various key insights into the market research report. The report on global Precision Medicine market demonstrates the important aspects that are anticipated to shape the growth of the market over the forecast period. The study also includes the analysis of the market size & forecast for the different segments and geographies.

The global Precision Medicine market is anticipated to reach at a notable value by the end of 2025. The market is envisioned to grow at a considerable CAGR over the forecast period i.e. 2020-2025. In the past years, the market has grown at a significant rate and is projected to showcase a lucrative growth in the upcoming years.

Get sample report@  https://www.kdmarketinsights.com/sample/6854

The growth of this market is attributed towards various relevant factors including comprehensive surge in global cases of cancer, patient’s increasing involvement in personal healthcare, integration of big data healthcare companies with pharma & biotech companies, increase in ageing population susceptible to diseases etc.

The study for global Precision Medicine market covers the key market growth indicators such as value and supply chain analysis, year-on-year (Y-o-Y) growth and compounded annual growth rate (CAGR), in the KDMI’s research report along with macroeconomic indicators & forecast factors. Also, the analysis of Porter’s Five Forces demonstrates the five forces which include buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in the global Precision Medicine market.

Impact of Coronavirus Disease (COVID-19) on Global Precision Medicine Market

The coronavirus or COVID-19 (formerly 2019-nCoV) broke out in December 2019, which has been imposed as a medical emergency worldwide. More than 213 countries and territories have reported cases of coronavirus to date. On 11th March 2020, the World Health Organization (WHO) declared the COVID-19 a pandemic officially. The study explains the impact of coronavirus disease (COVID-19) on global Precision Medicine market, covering the following points:

- Impact analysis of COVID-19 on the global Precision Medicine market in the upcoming years.

- Detailed research regarding each region & countries will be listed, to identify the issues caused by the coronavirus disease on the market.

- Strategies adopted by the major & prominent market players in order to survive in the situation of COVID-19 lockdown.

Get Complete Research Report with TOC@ https://www.kdmarketinsights.com/product/6854/precision-medicine-market

Key Insights Covered in the Global Precision Medicine Market Report

Analysis of market including the market forecast, Y-o-Y growth and structure of the industry.

Leading market growth factors, market trends and upcoming opportunities driving the growth of the market.

Identifying the barriers & threats hindering the market growth.

Detailed analysis of major & prominent players in the market & also covering a comprehensive analysis of the company’s business and performance.

Various market activities covering the market research report including product launch, innovation, acquisition, expansion, technological advancement, research & development & other market activities.

Segment Outlook

The global Precision Medicine market is segmented (By Technology, By Application, By End-use and By Target Audience). This market research report offers comprehensive data and information about the global Precision Medicine market dynamics & growth parameters related to these categories. Further, the market is sub-segmented as follows:

By Technology

Big Data Analytics

Bioinformatics

Gene Sequencing

Drug Discovery

Companion Diagnostics

Others

By Application

Oncology

Immunology

CNS

Respiratory

Others

By End-use

Pharmaceutical Companies

Diagnostic Companies

Healthcare IT companies

Others

By Target Audience

Medical device manufacturers and distributors

Government research organizations

Hospitals and clinics

Regulatory agencies

Pharmaceutical companies 

Enquiry Before Buying The Report @ https://www.kdmarketinsights.com/enquiry/6854

Regional Prospect

In terms of geography, the market for Precision Medicine is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In addition to this, further classification of market data and analysis of region into countries is covered in the report. Further, the geographies are fragmented into the regional & country groupings:

- North America (U.S. & Canada)

- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)

- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)

- Latin America (Brazil, Mexico and Rest of Latin America)

- Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa and Rest of Middle East & Africa)

Competitive Landscape

The market research report on the global Precision Medicine market also provides the detailed strategic analysis of the company’s business and performance including the financial information, revenue breakup by segment and by geography, SWOT Analysis, key factors, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news and other market activities. The market research report also provides company’s positioning and market share of the major & niche key market players in global Precision Medicine market. In addition to this, the report also profiles various major & niche key market players in the global Precision Medicine market including:

ABBOTT LABORATORIES

Almac Group

ASURAGEN

Cepheid Inc

CETICS Healthcare Technologies GmbH

GE Healthcare

Intomics A/S

Johnson & Johnson

LABORATORY CORPORATION OF AMERICA HOLDINGS

Medtronic, Novartis

Pfizer Inc

Qiagen

BIOBASE GmbH (Subsidiary)

Quest Diagnostics Inc

Randox Laboratories Ltd

Other Players

Get Discount report@ https://www.kdmarketinsights.com/discount/6854

About Us:

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant, and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.

Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

Contact Us:

KD Market Insights

150 State Street, Albany,

New York, USA 12207

+1 (518) 300-1215

Email: sales@kdmarketinsights.com

Website: www.kdmarketinsights.com

Precision Medicine Market Make Great Impact During 2018-2023

A fresh report titled “ Precision Medicine Market” has been presented by KD market research. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for Precision Medicine Market . The competition analysis is also a major part of the report. 

Precision medicine is an upcoming approach which involves investigating whether a person has any diseases by evaluating the genetic makeup, and then diagnosing it. According to Netscribes, the global precision medicine market is expected to have a significant compounded annual growth rate (CAGR) of 9.7% and have a market size in excess of USD 96 Bn by 2023. North America dominates the global market due to the high incidence of cancer and increasing government initiatives in the region.

Request sample report@ https://www.kdmarketresearch.com/sample/3108

Precision medicine involves a study of patient specific information to diagnose, and then categorize various diseases. The concept of precision medicine is rapidly growing in the medicine community through tremendous expansion in various advanced technologies, such as next-generation sequencing, molecular biomarker analysis, and much more. With the help of growing technologies, precision medicine plays a vital role in preventing and treating various diseases such as cancer, cardiovascular, neurology and other diseases, which are currently burdening the healthcare system.

The global precision medicine market is classified into three primary segments - based on end use: pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies; based on therapeutics: cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases; and based on sub-market: big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics.

Key growth factors

The concept of precision medicine has gained momentum in the healthcare community, powered by the tremendous expansion of various advanced technologies such as next-generation sequencing, molecular biomarker analysis and many more. Technological advancements have helped the precision medicine market prevent as well as treat diseases such as cancer, cardiovascular, neurology, diabetes, and others.

Rising pressure to lower healthcare cost globally, growth of personal healthcare devices, the emergence of value-based reimbursement models, and healthcare digitization trends are aiding the transition of treatment model from ‘one-size-fits-all’ to stratified and outcome-based targeted therapies, which are called precision medicine.

Threats and key players

Threat to personal data, high diagnostic costs, and the risk of hardware and software failure are some of the factors that will hinder the growth of the market.

The key players that have been contributing significantly to the precision medicine market include Abbott Laboratories, GE Healthcare, GlaxoSmithKline (GSK), Johnson & Johnson, Pfizer, Laboratories Corporation of America Holdings and Danaher Corporation, among others.

What’s covered in the report?

1. Overview of the global precision medicine market

2. Market Drivers and challenges in the global precision medicine market.

3. Market Trends in the global precision medicine market

4. Historical, current and forecasted market size data for end use segment in the global precision medicine market (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies)

5. Historical, current and forecasted market size data for the therapeutics segment in the global precision medicine market (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)

6. Historical, current and forecasted market size data for the sub-market segment in the global precision medicine market (big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics)

7. Analysis of the competitive landscape and profiles of major companies operating in the market

Why buy?

1. Get a broad understanding of the global precision medicine market, end uses, therapeutics, and the other sub-markets

2. Get geography-specific drivers and challenges affecting the global precision medicine market, its end uses, therapeutics, and the sub-markets

3. Devise market-entry strategies by understanding the factors driving the growth of the market
4. Identify the challenges and address them

5. Get insights into the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth

Access  Complete Research Report with toc@ https://www.kdmarketresearch.com/report/3108/global-precision-medicine-market-2018-2023

Table of Content

Chapter 1: Executive summary

1.1. Market scope and segmentation
1.2. Key questions answered in this study
1.3. Executive Summary

Chapter 2: Global precision medicine market - market overview

2.1. Global market overview - market trends, market attractiveness analysis, geography-wise market revenue (USD)
2.2. Global market drivers and challenges
2.3. Value chain analysis – precision medicine market
2.4. Porter’s Five Forces Analysis
2.5. Market segmentation based on end use (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
2.5.  a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5.  b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5.  c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5.  d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. Market segmentation for therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
2.6.  a. Revenue from cancer therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6.  b. Revenue from cardiovascular therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6.  c. Revenue from central nervous system therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6.  d. Revenue from psychiatric disorder therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6.  e. Revenue from infectious diseases therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. Market segmentation based on sub-market (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
2.7.  a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7.  b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7.  c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7.  d. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7.  e. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 3: North America precision medicine market - market overview

3.1. Market overview - market trends, market attractiveness analysis, geography wise market revenue (USD)
3.2. North America - market drivers and challenges
3.3. Market segmentation based on end use (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
3.3.  a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3.  b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3.  c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3.  d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. Market segmentation based on therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
3.4.  a. Revenue from cancer therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4.  b. Revenue from cardiovascular therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4.  c. Revenue from central nervous system therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4.  d. Revenue from psychiatric disorder therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4.  e. Revenue from infectious diseases therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.5. Market segmentation based on sub-market (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
3.5.  a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.5.  b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.5.  c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.5.  d. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.5.  e. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 4: Europe precision medicine market- market overview

4.1. Market overview - market trends, market attractiveness analysis, geography wise market revenue (USD)
4.2. Europe - market drivers and challenges
4.3. Market segmentation based on end use (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
4.3.  a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3.  b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3.  c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3.  d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4. Market segmentation based on therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
4.4.  a. Revenue in cancer therapeutics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4.  b. Revenue from cardiovascular therapeutics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4.  c. Revenue from central nervous system therapeutics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4.  d. Revenue from psychiatric disorder therapeutics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4.  e. Revenue from infectious diseases therapeutics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.5. Market segmentation based on sub-market (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
4.5.  a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.5.  b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.5.  c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.5.  d. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.5.  e. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 5: Asia-Pacific precision medicine market - market overview

5.1. Market overview - market trends, market attractiveness analysis, geography wise market revenue (USD)
5.2. Asia-Pacific - market drivers and challenges
5.3. Market segmentation based on end use (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
5.3.  a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3.  b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3.  c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3.  d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4. Market segmentation based on therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
5.4.  a. Revenue from cancer therapeutics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4.  b. Revenue from cardiovascular therapeutics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4.  c. Revenue from central nervous system therapeutics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4.  d. Revenue from psychiatric disorder therapeutics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4.  e. Revenue from infectious diseases therapeutics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.5. Market segmentation based on sub-market (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
5.5.  a. Revenue from big data analytics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.5.  b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.5.  c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.5.  d. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.5.  e. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 6: Latin America precision medicine market - market overview

6.1. Market overview - market trends, market attractiveness analysis, geography wise market revenue (USD)
6.2. Latin America - market drivers and challenges
6.3. Market segmentation based on end use (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
6.3.  a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
6.3.  b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
6.3.  c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
6.3.  d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
6.4. Market segmentation based on therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
6.4.  a. Revenue from cancer therapeutics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
6.4.  b. Revenue from cardiovascular therapeutics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
6.4.  c. Revenue from central nervous system therapeutics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
6.4.  d. Revenue from psychiatric disorder therapeutics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
6.4.  e. Revenue from infectious diseases therapeutics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
6.5. Market segmentation based on sub-market (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
6.5.  a. Revenue from big data analytics- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
6.5.  b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
6.5.  c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
6.5.  d. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
6.5.  e. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 7: Middle East and Africa precision medicine market - market overview

7.1. Market overview-market trends, market attractiveness analysis, geography wise market revenue (USD)
7.2. Middle East and Africa - market drivers and challenges
7.3. Market segmentation based on end use (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
7.3.  a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
7.3.  b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
7.3.  c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
7.3.  d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
7.4. Market segmentation based on therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
7.4.  a. Revenue from cancer therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
7.4.  b. Revenue from cardiovascular therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
7.4.  c. Revenue from central nervous system therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
7.4.  d. Revenue from psychiatric disorder therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
7.4.  e. Revenue from infectious diseases therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
7.5. Market segmentation based on sub-market (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
7.5.  a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
7.5.  b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
7.5.  c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
7.5.  d. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
7.5.  e. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Continue…..

Check Exclusive Discount on this Report @ https://www.kdmarketresearch.com/discount/3108

About Us:

KD Market Research is one of the best market research organization that provides B2B research on the growth opportunities of the industry which is the prime factor of the overall revenue of the organization. We identify the pain points which our client is facing around revenue methods and provide them with a comprehensive database which helps them to make intelligent decisions that could ensure growth to the organization.

Our Services include market intelligence, competitive intelligence, and customized research. These research reports help the organizations to make quick and powerful decisions that make out highest growth in revenue.

Contact us -

KD Market Research

150 State Street, Albany,

New York, USA 12207

Website: www.kdmarketresearch.com

Email id-  sales@kdmarketresearch.com

Read More :https://kdmarketresearch.blogspot.com/

https://news4blogspot.blogspot.com/

https://reportkd.blogspot.com/

Precision Medicine Market to Witness Huge Growth with Projected CAGAR of 11.60% during Forecast Year 2018-2023

A fresh report titled “ Precision Medicine Market  ” has been presented by KD market research. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for  Precision Medicine Market . The competition analysis is also a major part of the report. 

The global precision medicine market has benefitted greatly from advancements in the life science industry. Although in its nascent stage, targeted therapies hold high chances of becoming a massive success in the coming years because of the potential to treat and cure chronic illnesses. The market is thus expected to expand at a compound annual growth rate (CAGR) of 11.60% between 2018 and 2023, generating USD 88.25 Bn in revenue by 2023.

Request sample report@ https://www.kdmarketresearch.com/sample/3125

Ecosystem player segment insights

Diagnostic companies held the largest share of the market in 2018, contributing to approximately 39% of the global revenues. They are expected to continue dominating the market during the assessment period, owing to the dominant role that precision medicine plays in diagnosing potential diseases. Pharmaceutical companies are next in line to dominate the market, accounting for a market share of 29% in 2018 due to the increasing efforts put in research and development for developing drugs.

Therapeutic segment insights

Among the therapeutic areas of precision medicine, cancer held the largest share of the market by generating almost 33% of the global market revenue in 2018. Development of targeted novel therapies and precision medicines for treating cancer, owing to its increasing prevalence worldwide, will drive its growth in the foreseeable future. Central nervous system (CNS) disorders and infectious diseases held market shares of 20% and 16%, respectively. The precision medicine market for respiratory diseases is foreseen to grow at a very high rate, owing to the growth of diseases such as asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis, etc.  

Technology segment insights

Pharmacogenomics held the largest market share (24%) in 2018, followed by genomics. The technological and analytical developments in genomics have made it easier to identify and interpret the genetic variation underlying a disease, thereby contributing to the rapid growth of genomics. The market for genomics is also projected to expand at the highest CAGR of 13.67% during 2018–2023. Big data analytics is also expected to show fast growth during the forecast period.

Regional insights

North America leads the global precision medicine market with a share of 43%, followed by Europe with a 26% share. These regions are primarily driven by supportive policies and initiatives by the government, a strong presence of market players, and quick adoption of advanced healthcare technology and practices. Asia-Pacific is expected to emerge as the fastest growing region in this market with the highest CAGR of 13% during the forecast period.

Companies covered

• Abbott Laboratories
• GE Healthcare
• GlaxoSmithKline (GSK)
• Johnson & Johnson
• Pfizer
• Randox Laboratories
• Almac Group
• Novartis AG
• Teva Pharmaceutical industries
• Quest Diagnostics

Browse Complete  Research Report with toc@ https://www.kdmarketresearch.com/report/3125/global-precision-medicine-market-2019-2023

Table of Content

Chapter 1. Executive summary

1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary

Chapter 2. Global precision medicine market – overview

2.1. Global market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), geography-wise market revenue (USD Bn), and market attractiveness analysis
2.2. Global market drivers
2.3. Global market trends
2.4. Global market challenges
2.5. Value chain analysis
2.6. Porter's five forces analysis
2.7. Market segmentation based on ecosystem players (pharmaceutical and biotechnology companies, clinical laboratories, diagnostic companies, and healthcare IT/big data companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
2.8. Market segmentation based on therapeutics (cancer, cardiovascular diseases, central nervous system [CNS] disorders, psychiatric disorders, respiratory diseases, infectious diseases, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
2.9. Market segmentation based on technology (big data analytics, bioinformatics, genomics, pharmacogenomics, companion diagnostics, epigenetics, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations

Chapter 3. North America precision medicine market

3.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
3.2. Market segmentation based on ecosystem players (pharmaceutical and biotechnology companies, clinical laboratories, diagnostic companies, and healthcare IT/big data companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
3.3. Market segmentation based on therapeutics (cancer, cardiovascular diseases, central nervous system [CNS] disorders, psychiatric disorders, respiratory diseases, infectious diseases, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
3.4. Market segmentation based on technology (big data analytics, bioinformatics, genomics, pharmacogenomics, companion diagnostics, epigenetics, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations

Chapter 4. Europe precision medicine market

4.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
4.2. Market segmentation based on ecosystem players (pharmaceutical and biotechnology companies, clinical laboratories, diagnostic companies, and healthcare IT/big data companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
4.3. Market segmentation based on therapeutics (cancer, cardiovascular diseases, central nervous system [CNS] disorders, psychiatric disorders, respiratory diseases, infectious diseases, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
4.4. Market segmentation based on technology (big data analytics, bioinformatics, genomics, pharmacogenomics, companion diagnostics, epigenetics, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations

Chapter 5. Asia-Pacific precision medicine market

5.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
5.2. Market segmentation based on ecosystem players (pharmaceutical and biotechnology companies, clinical laboratories, diagnostic companies, and healthcare IT/big data companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
5.3. Market segmentation based on therapeutics (cancer, cardiovascular diseases, central nervous system [CNS] disorders, psychiatric disorders, respiratory diseases, infectious diseases, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
5.4. Market segmentation based on technology (big data analytics, bioinformatics, genomics, pharmacogenomics, companion diagnostics, epigenetics, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations

Chapter 6. Latin America precision medicine market

6.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
6.2. Market segmentation based on ecosystem players (pharmaceutical and biotechnology companies, clinical laboratories, diagnostic companies, and healthcare IT/big data companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
6.3. Market segmentation based on therapeutics (cancer, cardiovascular diseases, central nervous system [CNS] disorders, psychiatric disorders, respiratory diseases, infectious diseases, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
6.4. Market segmentation based on technology (big data analytics, bioinformatics, genomics, pharmacogenomics, companion diagnostics, epigenetics, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations

Chapter 7. The Middle East and Africa precision medicine market

7.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
7.2. Market segmentation based on ecosystem players (pharmaceutical and biotechnology companies, clinical laboratories, diagnostic companies, and healthcare IT/big data companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
7.3. Market segmentation based on therapeutics (cancer, cardiovascular diseases, central nervous system [CNS] disorders, psychiatric disorders, respiratory diseases, infectious diseases, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
7.4. Market segmentation based on technology (big data analytics, bioinformatics, genomics, pharmacogenomics, companion diagnostics, epigenetics, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations

Chapter 8. Competitive landscape

8.1. Abbott Laboratories
8.1.a. Company snapshot
8.1.b. Products/services
8.1.c. Major initiatives/highlights
8.1.d. Growth strategy
8.1.e. Key people
8.1.f. Global presence
Note: Similar information areas will be covered for the remaining competitors:
8.2. GE Healthcare
8.3. GlaxoSmithKline
8.4. Johnson & Johnson
8.5. Pfizer
8.6. Randox Laboratories
8.7. Almac Group
8.8. Novartis AG
8.9. Teva Pharmaceutical Industries Ltd.
8.10. Quest Diagnostics

Chapter 9 Conclusion
9.1. Future outlook

Appendix
• List of tables
• Research methodology
• Assumptions

Request Exclusive Discount on this Report @ https://www.kdmarketresearch.com/discount/3125

About Us:

KD Market Research is one of the best market research organization that provides B2B research on the growth opportunities of the industry which is the prime factor of the overall revenue of the organization. We identify the pain points which our client is facing around revenue methods and provide them with a comprehensive database which helps them to make intelligent decisions that could ensure growth to the organization.

Our Services include market intelligence, competitive intelligence, and customized research. These research reports help the organizations to make quick and powerful decisions that make out highest growth in revenue.

Contact us -

KD Market Research

150 State Street, Albany,

New York, USA 12207

Website: www.kdmarketresearch.com

Email id-  sales@kdmarketresearch.com

Read More :https://kdmarketresearch.blogspot.com/

https://pharmaceuticalindustryupdate.blogspot.com/